共 68 条
The Human Vaccines Project: A roadmap for cancer vaccine development
被引:172
作者:
Romero, Pedro
[1
]
Banchereau, Jacques
[2
]
Bhardwaj, Nina
[3
]
Cockett, Mark
[4
,29
]
Disis, Mary L.
[5
]
Dranoff, Glenn
[6
]
Gilboa, Eli
[7
]
Hammond, Scott A.
[8
]
Hershberg, Robert
[9
]
Korman, Alan J.
[10
]
Kvistborg, Pia
[11
]
Melief, Cornelis
[12
,13
]
Mellman, Ira
[14
]
Palucka, A. Karolina
[2
,15
]
Redchenko, Irina
[16
]
Robins, Harlan
[17
]
Sallusto, Federica
[18
]
Schenkelberg, Theodore
[19
]
Schoenberger, Stephen
[20
,21
]
Sosman, Jeffrey
[22
,23
]
Tuereci, Oezlem
[24
]
Van den Eynde, Benoit
[25
,26
,27
]
Koff, Wayne
[28
]
Coukos, George
[1
]
机构:
[1] Univ Lausanne, Ludwig Canc Res, CH-1066 Epalinges, Switzerland
[2] Jackson Lab Genom Med, Farmington, CT 06032 USA
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[4] Bristol Myers Squibb Co, 5 Res Pkwy, Wallingford, CT 06492 USA
[5] Univ Washington, Sch Med, Seattle, WA 98109 USA
[6] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[7] Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[8] Medimmune Inc, Gaithersburg, MD 20878 USA
[9] Celgene Immunooncol Ctr Excellence, 1616 Eastlake Ave,Suite 500, Seattle, WA 98102 USA
[10] Bristol Myers Squibb, Biol Discovery Calif, Redwood City, CA 94063 USA
[11] Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[12] ISA Pharmaceut, NL-2333 ZA Leiden, Netherlands
[13] Leiden Univ, Med Ctr, NL-2333 ZA Leiden, Netherlands
[14] Genentech Inc, San Francisco, CA 94080 USA
[15] Baylor Inst Immunol Res, Dallas, TX 75204 USA
[16] Univ Oxford, Oxford OX3 7DQ, England
[17] Fred Hutchinson Canc Res Ctr, Adapt Biotechnol, Seattle, WA 98102 USA
[18] Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland
[19] West Monument Consulting, 1906 R St NW St 11, Washington, DC 20009 USA
[20] La Jolla Inst Allergy & Immunol, Ctr Personalized Canc Immunotherapy, San Diego, CA 92037 USA
[21] UCSD Moores Canc Ctr, San Diego, CA 92037 USA
[22] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA
[23] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
[24] CI3 Cluster Individualized Immunotherapy, Kupferbergterasse 17-19, D-55131 Mainz, Germany
[25] Ludwig Inst Canc Res, Brussels Branch, BRU-1200 Brussels, Belgium
[26] Catholic Univ Louvain, Ave Hippocrate 10, B-1200 Woluwe St Lambert, Belgium
[27] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Med, Old Rd Campus Res Bldg, Oxford OX3 7DQ, England
[28] Int AIDS Vaccines Initiat, 125 Broad St,9th Floor, New York, NY 10004 USA
[29] ViiV Healthcare, 5 Res Pkwy, Wallingford, CT 06492 USA
关键词:
T-CELL DIFFERENTIATION;
RANDOMIZED CONTROLLED-TRIAL;
DENDRITIC CELLS;
LUNG-CANCER;
INTRAEPITHELIAL NEOPLASIA;
THERAPEUTIC VACCINES;
CHECKPOINT BLOCKADE;
IMMUNE-RESPONSE;
PROSTATE-CANCER;
IMMUNOTHERAPY;
D O I:
10.1126/scitranslmed.aaf0685
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
Cancer vaccine development has been vigorously pursued for 40 years. Immunity to tumor antigens can be elicited by most vaccines tested, but their clinical efficacy remains modest. We argue that a concerted international effort is necessary to understand the human antitumor immune response and achieve clinically effective cancer vaccines.
引用
收藏
页数:7
相关论文